1. Home
  2. WFC vs ABT Comparison

WFC vs ABT Comparison

Compare WFC & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WFC
  • ABT
  • Stock Information
  • Founded
  • WFC 1852
  • ABT 1888
  • Country
  • WFC United States
  • ABT United States
  • Employees
  • WFC N/A
  • ABT N/A
  • Industry
  • WFC Major Banks
  • ABT Medical/Dental Instruments
  • Sector
  • WFC Finance
  • ABT Health Care
  • Exchange
  • WFC Nasdaq
  • ABT Nasdaq
  • Market Cap
  • WFC 249.8B
  • ABT 221.0B
  • IPO Year
  • WFC N/A
  • ABT N/A
  • Fundamental
  • Price
  • WFC $67.28
  • ABT $132.65
  • Analyst Decision
  • WFC Buy
  • ABT Buy
  • Analyst Count
  • WFC 20
  • ABT 18
  • Target Price
  • WFC $73.76
  • ABT $136.06
  • AVG Volume (30 Days)
  • WFC 17.7M
  • ABT 5.9M
  • Earning Date
  • WFC 04-11-2025
  • ABT 04-16-2025
  • Dividend Yield
  • WFC 2.37%
  • ABT 1.77%
  • EPS Growth
  • WFC 11.18
  • ABT 134.36
  • EPS
  • WFC 5.37
  • ABT 7.64
  • Revenue
  • WFC $77,962,000,000.00
  • ABT $41,950,000,000.00
  • Revenue This Year
  • WFC $10.01
  • ABT $6.72
  • Revenue Next Year
  • WFC $4.49
  • ABT $7.45
  • P/E Ratio
  • WFC $12.44
  • ABT $17.41
  • Revenue Growth
  • WFC 0.99
  • ABT 4.59
  • 52 Week Low
  • WFC $50.15
  • ABT $99.71
  • 52 Week High
  • WFC $81.50
  • ABT $141.23
  • Technical
  • Relative Strength Index (RSI)
  • WFC 26.64
  • ABT 50.03
  • Support Level
  • WFC $65.52
  • ABT $133.46
  • Resistance Level
  • WFC $78.98
  • ABT $139.15
  • Average True Range (ATR)
  • WFC 2.59
  • ABT 2.90
  • MACD
  • WFC -1.30
  • ABT -0.70
  • Stochastic Oscillator
  • WFC 11.92
  • ABT 13.16

About WFC Wells Fargo & Company

Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Share on Social Networks: